Amarin Corp Plc (AMRN)

[KCSVEN]

By far the biggest reason FDA Priority was huge, End of September is so much better then January for expediting tier changes.

It will take time but in 2021 Generic Lovaza will be wholly replaced by Vascepa (means if that was today the V scripts would double). I believe FDA approval and tier changes in particular are a huge catalyst to be easily 2 billion in sales in 2021 minimum. Tiers will change in 2020 but it's a rolling effect between getting the tier changed and getting people in for there annual visit. 2020 will see accelerated growth but believe 2021 is when it finally goes ballistic. (Inventory increase, insurance tiers well established, marketing penetration high, debt completely paid off).